Status:
WITHDRAWN
Psychodynamic Psychotherapy for Psychosis
Lead Sponsor:
Yale University
Collaborating Sponsors:
University of Southern California
American Psychoanalytic Association
Conditions:
Psychotic Disorders
Eligibility:
All Genders
16-35 years
Phase:
NA
Brief Summary
The broad goals of our pilot study are to (1) determine whether psychodynamic psychotherapy for psychosis (PPfP), relative to treatment as usual (TaU), can maintain or augment clinical and functional ...
Eligibility Criteria
Inclusion
- completed the 2-3 year Coordinated Specialty Care (CSC) program
- judged by present provider to be in an intermediate or advanced phase of recovery
- had first episode of psychosis within the 3 years prior to enrollment
Exclusion
- established diagnosis of primary affective disorder, psychosis secondary to substance use or a medical illness
- inability to communicate in English
- eligibility for Department of Developmental Services
- legally mandated to enter treatment.
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04415541
Start Date
May 1 2021
End Date
August 1 2021
Last Update
October 25 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.